Cargando…

Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication

Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the preva...

Descripción completa

Detalles Bibliográficos
Autores principales: Watad, Abdulla, Kacar, Mark, Bragazzi, Nicola Luigi, Zhou, Qiao, Jassam, Miriam, Taylor, Jan, Roman, Eve, Smith, Alexandra, Jones, Richard A., Amital, Howard, Cargo, Catherine, McGonagle, Dennis, Savic, Sinisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933213/
https://www.ncbi.nlm.nih.gov/pubmed/33679746
http://dx.doi.org/10.3389/fimmu.2021.610019
_version_ 1783660561301504000
author Watad, Abdulla
Kacar, Mark
Bragazzi, Nicola Luigi
Zhou, Qiao
Jassam, Miriam
Taylor, Jan
Roman, Eve
Smith, Alexandra
Jones, Richard A.
Amital, Howard
Cargo, Catherine
McGonagle, Dennis
Savic, Sinisa
author_facet Watad, Abdulla
Kacar, Mark
Bragazzi, Nicola Luigi
Zhou, Qiao
Jassam, Miriam
Taylor, Jan
Roman, Eve
Smith, Alexandra
Jones, Richard A.
Amital, Howard
Cargo, Catherine
McGonagle, Dennis
Savic, Sinisa
author_sort Watad, Abdulla
collection PubMed
description Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the prevalence of autoinflammatory complications and its link with karyotypes and somatic mutation status. Autoinflammatory complications were described either as well-defined autoinflammatory diseases (AD) or undifferentiated “autoinflammatory disease” (UAD) (defined as CRP over 10.0 mg/L on five consecutive occasions, taken at separate times and not explained by infection). Several patient characteristics including demographic, clinical, laboratory, cytogenetics charts, and outcomes, were compared between different groups. Results: Sixty-two (46.3%) patients had an autoinflammatory complication manifesting as arthralgia (43.5% vs. 23.6%, p = 0.0146), arthritis (30.6% vs. 15.3%, p = 0.0340), skin rash (27.4% vs. 12.5%, p = 0.0301), pleuritis (14.5% vs. 4.2%, p = 0.0371) and unexplained fever (27.4% vs. 0%, p < 0.0001). AD were found in 7.4% of MDS patients (with polymyalgia rheumatic being the most frequently one). Classical autoimmune diseases were found only in 4 MDS patients (3.0%). Transcription factor pathway mutations (RUNX1, BCOR, WTI, TP53) (OR 2.20 [95%CI 1.02–4.75], p = 0.0451) and abnormal karyotypes (OR 2.76 [95%CI 1.22–6.26], p = 0.0153) were associated with autoinflammatory complications. Acute leukaemic transformation was more frequent in MDS patients with autoinflammatory features than those without (27.4% vs. 9.7%, p = 0.0080). Conclusions: Autoinflammatory complications are common in MDS. Somatic mutations of transcription factor pathways and abnormal karyotypes are associated with greater risk of autoinflammatory complications, which are themselves linked to malignant transformation and a worse prognosis.
format Online
Article
Text
id pubmed-7933213
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-79332132021-03-06 Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication Watad, Abdulla Kacar, Mark Bragazzi, Nicola Luigi Zhou, Qiao Jassam, Miriam Taylor, Jan Roman, Eve Smith, Alexandra Jones, Richard A. Amital, Howard Cargo, Catherine McGonagle, Dennis Savic, Sinisa Front Immunol Immunology Objectives: We theorized that myelodysplastic syndrome (MDS) with somatic mutations and karyotype abnormalities are associated with autoinflammation, and that the presence of autoinflammatory disease affected prognosis in MDS. Methods: One hundred thirty-four MDS patients were assessed for the prevalence of autoinflammatory complications and its link with karyotypes and somatic mutation status. Autoinflammatory complications were described either as well-defined autoinflammatory diseases (AD) or undifferentiated “autoinflammatory disease” (UAD) (defined as CRP over 10.0 mg/L on five consecutive occasions, taken at separate times and not explained by infection). Several patient characteristics including demographic, clinical, laboratory, cytogenetics charts, and outcomes, were compared between different groups. Results: Sixty-two (46.3%) patients had an autoinflammatory complication manifesting as arthralgia (43.5% vs. 23.6%, p = 0.0146), arthritis (30.6% vs. 15.3%, p = 0.0340), skin rash (27.4% vs. 12.5%, p = 0.0301), pleuritis (14.5% vs. 4.2%, p = 0.0371) and unexplained fever (27.4% vs. 0%, p < 0.0001). AD were found in 7.4% of MDS patients (with polymyalgia rheumatic being the most frequently one). Classical autoimmune diseases were found only in 4 MDS patients (3.0%). Transcription factor pathway mutations (RUNX1, BCOR, WTI, TP53) (OR 2.20 [95%CI 1.02–4.75], p = 0.0451) and abnormal karyotypes (OR 2.76 [95%CI 1.22–6.26], p = 0.0153) were associated with autoinflammatory complications. Acute leukaemic transformation was more frequent in MDS patients with autoinflammatory features than those without (27.4% vs. 9.7%, p = 0.0080). Conclusions: Autoinflammatory complications are common in MDS. Somatic mutations of transcription factor pathways and abnormal karyotypes are associated with greater risk of autoinflammatory complications, which are themselves linked to malignant transformation and a worse prognosis. Frontiers Media S.A. 2021-02-19 /pmc/articles/PMC7933213/ /pubmed/33679746 http://dx.doi.org/10.3389/fimmu.2021.610019 Text en Copyright © 2021 Watad, Kacar, Bragazzi, Zhou, Jassam, Taylor, Roman, Smith, Jones, Amital, Cargo, McGonagle and Savic. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Watad, Abdulla
Kacar, Mark
Bragazzi, Nicola Luigi
Zhou, Qiao
Jassam, Miriam
Taylor, Jan
Roman, Eve
Smith, Alexandra
Jones, Richard A.
Amital, Howard
Cargo, Catherine
McGonagle, Dennis
Savic, Sinisa
Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title_full Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title_fullStr Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title_full_unstemmed Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title_short Somatic Mutations and the Risk of Undifferentiated Autoinflammatory Disease in MDS: An Under-Recognized but Prognostically Important Complication
title_sort somatic mutations and the risk of undifferentiated autoinflammatory disease in mds: an under-recognized but prognostically important complication
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933213/
https://www.ncbi.nlm.nih.gov/pubmed/33679746
http://dx.doi.org/10.3389/fimmu.2021.610019
work_keys_str_mv AT watadabdulla somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT kacarmark somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT bragazzinicolaluigi somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT zhouqiao somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT jassammiriam somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT taylorjan somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT romaneve somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT smithalexandra somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT jonesricharda somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT amitalhoward somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT cargocatherine somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT mcgonagledennis somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication
AT savicsinisa somaticmutationsandtheriskofundifferentiatedautoinflammatorydiseaseinmdsanunderrecognizedbutprognosticallyimportantcomplication